loadpatents
name:-0.040556192398071
name:-0.04332709312439
name:-0.0068199634552002
FOWLER; Kerry W. Patent Filings

FOWLER; Kerry W.

Patent Applications and Registrations

Patent applications and USPTO patent grants for FOWLER; Kerry W..The latest application filed is for "quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta".

Company Profile
5.38.32
  • FOWLER; Kerry W. - Seattle WA
  • Fowler; Kerry W. - Chicago IL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Quinazolinones As Inhibitors Of Human Phosphatidylinositol 3-kinase Delta
App 20210332047 - KESICKI; Edward A. ;   et al.
2021-10-28
Tert-butyl (s)-(1-(5-fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)prop- yl)carbamate precursor of a quinazolinone inhibitor of human phosphatidylinositol 3-kinase delta and a process for preparing thereof
Grant 10,906,907 - Kesicki , et al. February 2, 2
2021-02-02
Anti-viral Compounds, Pharmaceutical Compositions, And Methods Of Use Thereof
App 20200270274 - Iadonato; Shawn P. ;   et al.
2020-08-27
Quinazolinones As Inhibitors Of Human Phosphatidylinositol 3-kinase Delta
App 20200017503 - KESICKI; Edward A. ;   et al.
2020-01-16
(S)-2-(1-aminopropyl)-5-fluoro-3-phenylquinazolin-4(3H)-one precursor of a quinazolinone as inhibitor of human phosphatidylinositol 3-kinase delta
Grant 10,336,756 - Kesicki , et al.
2019-07-02
Anti-viral Compounds, Pharmaceutical Compositions, And Methods Of Use Thereof
App 20190002477 - Iadonato; Shawn P. ;   et al.
2019-01-03
Anti-viral compounds
Grant 9,956,285 - Iadonato , et al. May 1, 2
2018-05-01
Anti-viral compounds, pharmaceutical compositions, and methods of use thereof
Grant 9,884,876 - Iadonato , et al. February 6, 2
2018-02-06
Anti-viral Compounds
App 20170258897 - Iadonato; Shawn P. ;   et al.
2017-09-14
Anti-viral Compounds, Pharmaceutical Compositions, And Methods Of Use Thereof
App 20170057978 - Iadonato; Shawn P. ;   et al.
2017-03-02
Anti-viral compounds
Grant 9,555,106 - Iadonato , et al. January 31, 2
2017-01-31
Anti-viral Compounds, Pharmaceutical Compositions And Methods Of Use Thereof
App 20160122312 - Iadonato; Shawn P. ;   et al.
2016-05-05
Anti-viral Compounds
App 20160102099 - Iadonato; Shawn P. ;   et al.
2016-04-14
Quinazolinones As Inhibitors Of Human Phosphatidylinositol 3-kinase Delta
App 20160075705 - KESICKI; Edward A. ;   et al.
2016-03-17
Anti-viral Compounds
App 20150342932 - Iadonato; Shawn P. ;   et al.
2015-12-03
5-fluoro-3-phenyl-2-[1-(9h-purin-6-ylamino)propyl]-3h-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta
Grant 9,149,477 - Kesicki , et al. October 6, 2
2015-10-06
Anti-viral compounds
Grant 9,073,946 - Iadonato , et al. July 7, 2
2015-07-07
5-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase delta
Grant 8,993,583 - Fowler , et al. March 31, 2
2015-03-31
5-fluoro-3-phenyl-2[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase delta
Grant 8,980,901 - Fowler , et al. March 17, 2
2015-03-17
Quinazolinones As Inhibitors Of Human Phosphatidylinositol 3-kinase Delta
App 20140378479 - KESICKI; Edward A. ;   et al.
2014-12-25
Anti-viral Compounds
App 20140227320 - Iadonato; Shawn P. ;   et al.
2014-08-14
Anti-viral Compounds
App 20140227321 - Iadonato; Shawn P. ;   et al.
2014-08-14
Anti-Viral Compounds
App 20140199348 - Iadonato; Shawn P. ;   et al.
2014-07-17
6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)-ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta
Grant 8,779,131 - Kesicki , et al. July 15, 2
2014-07-15
Quinazolinones As Inhibitors Of Human Phosphatidyositol 3-kinase Delta
App 20140121224 - FOWLER; Kerry W. ;   et al.
2014-05-01
Quinazolinones As Inhibitors Of Human Phosphatidylinositol 3-kinase Delta
App 20140121223 - Fowler; Kerry W. ;   et al.
2014-05-01
Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
Grant RE44,638 - Fowler , et al. December 10, 2
2013-12-10
6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta
Grant 8,586,597 - Fowler , et al. November 19, 2
2013-11-19
Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
Grant RE44,599 - Fowler , et al. November 12, 2
2013-11-12
Quinazolinones As Inhibitors Of Human Phosphatidylinositol 3-kinase Delta
App 20130231356 - KESICKI; Edward A. ;   et al.
2013-09-05
Quinazolinones As Inhibitors Of Human Phosphatidylinositol 3-kinase Delta
App 20130116266 - FOWLER; Kerry W. ;   et al.
2013-05-09
Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
Grant 8,207,153 - Fowler , et al. June 26, 2
2012-06-26
Quinazolinones As Inhibitors Of Human Phosphatidylinositol 3-kinase Delta
App 20120015964 - Fowler; Kerry W. ;   et al.
2012-01-19
Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
Grant 7,932,260 - Fowler , et al. April 26, 2
2011-04-26
Quinazolinones As Inhibitors Of Human Phosphatidylinositol 3-kinase Delta
App 20100256167 - Fowler; Kerry W. ;   et al.
2010-10-07
Quinazolinones As Inhibitors Of Human Phosphatidylinositol 3-kinase Delta
App 20100256168 - Fowler; Kerry W. ;   et al.
2010-10-07
Quinazolinones as Inhibitors of Human Phosphatidylinositol 3-Kinase Delta
App 20080275067 - Fowler; Kerry W. ;   et al.
2008-11-06
Arylphenylamino-,Arylphenylamide-, and Arylphenylether-Sulfide Derivatives
App 20070259863 - Chin; Donovan ;   et al.
2007-11-08
Cyclic AMP-specific phosphodiesterase inhibitors
Grant 7,176,229 - Martins , et al. February 13, 2
2007-02-13
Cyclic AMP-specific phosphodiesterase inhibitors
Grant 7,087,634 - Martins , et al. August 8, 2
2006-08-08
Cyclic AMP-specific phosphodiesterase inhibitors
App 20060074123 - Martins; Timothy J. ;   et al.
2006-04-06
Cyclic AMP-specific phosphodiesterase inhibitors
Grant 6,998,416 - Martins , et al. February 14, 2
2006-02-14
PARP inhibitors
Grant 6,924,284 - Beaton , et al. August 2, 2
2005-08-02
Cyclic AMP-specific phosphodiesterase inhibitors
App 20040152754 - Martins, Timothy J. ;   et al.
2004-08-05
Parp inhibitors
App 20040087588 - Beaton, Graham ;   et al.
2004-05-06
Cyclic AMP-specific phosphodie sterase inhibitors
Grant 6,716,871 - Martins , et al. April 6, 2
2004-04-06
Cyclic Amp-specific Phosphodiesterase Inhibitors
App 20040023945 - Martins, Timothy J. ;   et al.
2004-02-05
Cyclic AMP-specific phosphodiesterase inhibitors
Grant 6,680,336 - Martins , et al. January 20, 2
2004-01-20
Cyclic AMP-specific phosphodiesterase inhibitors
App 20030236412 - Martins, Timothy J. ;   et al.
2003-12-25
Cyclic AMP-specific phosphodiesterase inhibitors
Grant 6,569,890 - Martins , et al. May 27, 2
2003-05-27
Cyclic AMP-specific phosphodiesterase inhibitors
Grant 6,569,885 - Martins , et al. May 27, 2
2003-05-27
Cyclic AMP-specific phosphodiesterase inhibitors
App 20030013754 - Martins, Timothy J. ;   et al.
2003-01-16
Cyclic AMP-specific phosphodiesterase inhibitors
Grant 6,500,856 - Fowler , et al. December 31, 2
2002-12-31
Thiazole compounds as cyclic AMP-specific phosphodiesterase inhibitors and method of using the same
Grant 6,486,186 - Fowler , et al. November 26, 2
2002-11-26
Cyclic AMP-specific phosphodiesterase inhibitors
Grant 6,458,787 - Martins , et al. October 1, 2
2002-10-01
Cyclic AMP-specific phosphodiesterase inhibitors
Grant 6,455,562 - Fowler , et al. September 24, 2
2002-09-24
Cyclic AMP-specific phosphodiesterase inhibitors
Grant 6,423,710 - Martins , et al. July 23, 2
2002-07-23
Cyclic AMP-specific phosphodiesterase inhibitors
App 20020065302 - Fowler, Kerry W. ;   et al.
2002-05-30
Cyclic AMP-specific phosphodiesterase inhibitors
Grant 6,376,489 - Martins , et al. April 23, 2
2002-04-23
Cyclic AMP-specific phosphodiesterase inhibitors
Grant 6,372,777 - Martins , et al. April 16, 2
2002-04-16
Cyclic AMP-specific phosphodiesterase inhibitors
App 20020042435 - Fowler, Kerry W. ;   et al.
2002-04-11
Cyclic AMP-specific phosphodiesterase inhibitors
App 20020032224 - Fowler, Kerry W. ;   et al.
2002-03-14
Cyclic AMP-specific phosphodiesterase inhibitors
Grant 6,348,602 - Fowler , et al. February 19, 2
2002-02-19
Cyclic AMP-specific phosphodiesterase inhibitors
Grant 6,258,833 - Martins , et al. July 10, 2
2001-07-10
Phenylacetonitrilehydroxyalkylaminoalkyl-ortho-substituted aryl compounds as immunosuppressives
Grant 5,247,119 - Fowler , et al. September 21, 1
1993-09-21
Substituted N-benzylpiperidine amides
Grant 5,098,915 - Desai , et al. March 24, 1
1992-03-24
N-benzyltropaneamides
Grant 5,070,094 - Fowler December 3, 1
1991-12-03
N-benzylpiperidine amides
Grant 5,028,616 - Desai , et al. July 2, 1
1991-07-02
Phenylpiperazine phosphonates
Grant 4,704,382 - Chorvat , et al. November 3, 1
1987-11-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed